Viking Therapeutics, Inc. (VKTX)
37.65
-0.33
(-0.87%)
USD |
NASDAQ |
Dec 09, 13:49
Viking Therapeutics Research and Development Expense (TTM): 222.48M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Pfizer Inc. | 10.13B |
| Amgen, Inc. | 6.828B |
| Altimmune, Inc. | 67.72M |
| Terns Pharmaceuticals, Inc. | 76.99M |